Psoriatic arthritis therapy ‘Guselkumab’ acquires approval in Korea
‘Guselkumab(product name: Tremfya Prefilled Syringe Inj),’ a Janssen’s psoriasis & arthritis therapy, acquired approval in Korea.
The Ministry of Food and Drug Safety(MFDS) decided new drug approval on ‘Tremfya Prefilled Syringe Inj(generic name: guselkumab),’ a Janssen Korea’s psoriasis & arthr...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
